Details for 2018873778

Up to date per 01.04.2026

Actions

Title / Product Name

IRAK4-INHIBITOR IN KOMBINATION MIT EINEM BCL-2-INHIBITOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018873778

EP Publication Number

3704108

E-Number

1678861

Language

PCT Number

US18058194

Publication Date

09.09.2020 A

24.04.2024 B1

Registration Date

24.04.2024

AT Publication Date

15.05.2024

Application Date

30.10.2018

Registration Number

Priorities

31.10.2017

201762579502 P

IPC

A61K 31/635 20060101AFI20231221BHEP

Maximum Duration of Protection

30.10.2038

Owner

Curis, Inc.Ledgemont Research Center-Building C-500 Level 128 Spring Street Lexington, MA 02421US

Representative

Dipl.- Ing. Jan Robert Naefec/o HGF Europe LLP, Rudolfskai 485020 SalzburgAT

Inventor

BOOHER, Robert1623 El Capitan Street Davis, CA 95616US

Information about Fees